Mary Newman

SVP, Regulatory Affairs, Audentes Therapeutics, Inc.

Companies

Audentes Therapeutics, Inc.SVP, Regulatory Affairs Jul 19, 2016 to Nov 16, 2018¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAudentes Therapeutics, Inc., SVP, Regulatory Affairs